Expression of excision repair cross-complementation group 1 as predictive marker for nasopharyngeal cancer treated with concurrent chemoradiotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/21621119

Int. J. Radiat. Oncol. Biol. Phys. 2011 Jul 1 80 3 655-60

Download in:

View as

General Info

PMID
21621119